Cargando…

LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities

Detalles Bibliográficos
Autores principales:	Santos, Jaime, Ventura, Salvador, Pallarès, Irantzu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827758/ https://www.ncbi.nlm.nih.gov/pubmed/36254986 http://dx.doi.org/10.4103/1673-5374.355757

Ejemplares similares

Electrostatically-guided inhibition of Curli amyloid nucleation by the CsgC-like family of chaperones
por: Taylor, Jonathan D., et al.
Publicado: (2016)

Bacterial Chaperones CsgE and CsgC Differentially Modulate Human α-Synuclein Amyloid Formation via Transient Contacts
por: Chorell, Erik, et al.
Publicado: (2015)

The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
por: Ridyard, Kylen E., et al.
Publicado: (2021)

Dissecting the contribution of Staphylococcus aureus α-phenol-soluble modulins to biofilm amyloid structure
por: Marinelli, Patrizia, et al.
Publicado: (2016)

Structural Insights into Curli CsgA Cross-β Fibril Architecture Inspire Repurposing of Anti-amyloid Compounds as Anti-biofilm Agents
por: Perov, Sergei, et al.
Publicado: (2019)

Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms
por: Kang, Jason, et al.
Publicado: (2019)

Metabolic Activation of CsgD in the Regulation of Salmonella Biofilms
por: Sokaribo, Akosiererem S., et al.
Publicado: (2020)

Synergistic Anti-Staphylococcal Activity Of Niosomal Recombinant Lysostaphin-LL-37
por: Sadeghi, Somayeh, et al.
Publicado: (2019)

Evaluation of antimicrobial peptide LL-37 for treatment of Staphylococcus aureus biofilm on titanium plate
por: Wei, Jiantong, et al.
Publicado: (2021)

Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
por: Zhuo, Haiwei, et al.
Publicado: (2022)

Force spectra of single bacterial amyloid CsgA nanofibers
por: Lv, Jingqi, et al.
Publicado: (2020)

Self-assembly of human latexin into amyloid-like oligomers
por: Pallarés, Irantzu, et al.
Publicado: (2007)

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
por: O’Neil, Liam J., et al.
Publicado: (2021)

CSG state directory.
Publicado: (2000)

I’ll Be Back
por: Rousseau, Paul
Publicado: (2016)

LL-37 Triggers Antimicrobial Activity in Human Platelets
por: Sánchez-Peña, Francisco Javier, et al.
Publicado: (2023)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
por: Osborne, Olivia M., et al.
Publicado: (2023)

Insights in peptide diffusion channels from the bacterial amyloid secretor CsgG
por: Van den Broeck, Imke, et al.
Publicado: (2015)

Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37
por: Dean, Scott N., et al.
Publicado: (2011)

Small RNAs in the control of RpoS, CsgD, and biofilm architecture of Escherichia coli
por: Mika, Franziska, et al.
Publicado: (2014)

CsgD regulatory network in a bacterial trait-altering biofilm formation
por: Liu, Zhen, et al.
Publicado: (2014)

The influence of cathelicidin LL37 in human anti-neutrophils cytoplasmic antibody (ANCA)-associated vasculitis
por: Zhang, Ying, et al.
Publicado: (2013)

Anti-adenoviral Effects of Human Cationic Antimicrobial Protein-18/LL-37, an Antimicrobial Peptide, by Quantitative Polymerase Chain Reaction
por: Uchio, Eiichi, et al.
Publicado: (2013)

The Disordered C-Terminus of Yeast Hsf1 Contains a Cryptic Low-Complexity Amyloidogenic Region
por: Pujols, Jordi, et al.
Publicado: (2018)

Cryptic amyloidogenic regions in intrinsically disordered proteins: Function and disease association
por: Santos, Jaime, et al.
Publicado: (2021)

Small molecules to target tau amyloid aggregation
por: Manglano-Artuñedo, Zoe, et al.
Publicado: (2023)

NMR insights into the pre-amyloid ensemble and secretion targeting of the curli subunit CsgA
por: Sewell, Lee, et al.
Publicado: (2020)

Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
por: Lande, Roberto, et al.
Publicado: (2020)

The coordinating evaluation and spatial correlation analysis of CSGC: A case study of Henan province, China
por: Xie, Mingxia, et al.
Publicado: (2017)

Anti-amyloid therapies for Alzheimer disease: finally, good news for patients
por: Ramanan, Vijay K., et al.
Publicado: (2023)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Significance of LL-37 on Immunomodulation and Disease Outcome
por: Yang, Binbin, et al.
Publicado: (2020)

Regulation of LL-37 in Bone and Periodontium Regeneration
por: Chinipardaz, Zahra, et al.
Publicado: (2022)

Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells
por: Muñoz, Mindy, et al.
Publicado: (2016)

Proteomic Adaptation of Streptococcus pneumoniae to the Human Antimicrobial Peptide LL-37
por: Mücke, Pierre-Alexander, et al.
Publicado: (2020)

Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
por: SZABÓ, Lilla, et al.
Publicado: (2023)

Computational prediction of protein aggregation: Advances in proteomics, conformation-specific algorithms and biotechnological applications
por: Santos, Jaime, et al.
Publicado: (2020)

Variability of Amyloid Propensity in Imperfect Repeats of CsgA Protein of Salmonella enterica and Escherichia coli
por: Szulc, Natalia, et al.
Publicado: (2021)

The Rho Termination Factor of Clostridium botulinum Contains a Prion-Like Domain with a Highly Amyloidogenic Core
por: Pallarès, Irantzu, et al.
Publicado: (2016)

Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
por: Frasca, Loredana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1f69hqujn129tlsak27qnc5vpq